Edralbrutinib
Product Specifications
CAS Number
1858206-58-2
Target
BTK
Related Pathways
Angiogenesis, Tyrosine Kinase/Adaptors
Purity
0.9947
Bioactivity
Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders. Additionally, Edralbrutinib is studied for its efficacy in membranous glomerulonephritis and optic neuromyelitis optica.
Smiles
O=C1C2=C(C(=CN2[C@H]3CN(C(C#CC)=O)CC3)C4=CC=C(OC5=C(F)C=CC=C5F)C=C4)C(N)=NN1
Molecular Formula
C26H21F2N5O3
Molecular Weight
489.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1263086-01 0.02 mg (E-Coli)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details MBS1263086-02 0.1 mg (E-Coli)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details MBS1263086-03 0.02 mg (Yeast)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details MBS1263086-04 0.1 mg (Yeast)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details MBS1263086-05 0.02 mg (Baculovirus)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details MBS1263086-06 1 mg (E-Coli)
Recombinant Human Ig lambda chain V-II region NIG-58
Sign In for Pricing
View Details